| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022283 |
| Receipt No. | R000025677 |
| Official scientific title of the study | A study for evaluating the effect of the intake of meal containing Salacia extract on postprandial hyperglycemia. |
| Date of disclosure of the study information | 2017/06/18 |
| Last modified on | 2018/10/24 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A study for evaluating the effect of the intake of meal containing Salacia extract on postprandial hyperglycemia. | |
| Title of the study (Brief title) | A study for evaluating the effect of the intake of meal containing plant extract on postprandial hyperglycemia. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of an plant extract containing meal on postprandial hyperglycemia |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Postprandial blood glucose
Area under the curve of plasma glucose |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Test meal with plant extract (single ingestion)-washout period- placebo meal without plant extract (single ingestion) | |
| Interventions/Control_2 | placebo meal without plant extract (single ingestion) -washout period- Test meal with plant extract (single ingestion) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Fasting blood glucose >=100,and <125mg/dl
2.Subjects who don't have drink alcohol over 25g/day 3.Subjects having no habit of any restriction of food 4.Subjects who don't going to hospital, medicine for present treatment 5.Subjects, upon briefing of the content of the present study, fully understands and agrees to its objective and is able to personally give written informed consent |
|||
| Key exclusion criteria | 1.Subjects having possibilities for emerging allergy related to the study
2.Pregnant women, or women with intending to become pregnant, and lactating woman. 3.Person who donated more than 200ml of blood within 1 month or 400ml of blood within 3 months prior to the study 4.Subjects who is participating in another clinical trial 5.Subjects who don't follow the instructions from the doctor or the staff 6.Subjects judged by the doctor to be unsuitable |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiko Fujisawa |
| Organization | Ageokousei Hospital |
| Division name | Director |
| Address | 421-1 , Jitoukata, Ageo-shi, Saitama |
| TEL | 048-781-1101 |
| masayuki.nakamura@achs.jp | |
| Public contact | |
| Name of contact person | Hitomi Nasu |
| Organization | QOL RD Co.,Ltd. |
| Division name | CRO Department Food Division |
| Address | 2-14-1, Nihonbashi, Chuo-Ku, Tokyo, Japan |
| TEL | 03-6386-8809 |
| Homepage URL | |
| h-nasu@qol-rd.co.jp | |
| Sponsor | |
| Institute | QOL RD Co.,Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yoshinoya holdings |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | http://www.toukastress.jp/webj/month/2017/page-2 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025677 |